Cinemark Holdings, Inc. (NYSE:CNK) Shares Acquired by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC grew its holdings in Cinemark Holdings, Inc. (NYSE:CNK – Get Rating) by 5.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,341 shares of the company’s stock after acquiring an additional 795 shares during the period. Mutual of America Capital Management LLC’s holdings in Cinemark were worth $265,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CNK. Point72 Hong Kong Ltd acquired a new position in Cinemark in the fourth quarter valued at $32,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in shares of Cinemark in the fourth quarter valued at about $37,000. GHP Investment Advisors Inc. purchased a new position in Cinemark during the first quarter worth about $89,000. Geneos Wealth Management Inc. raised its holdings in Cinemark by 80.7% during the fourth quarter. Geneos Wealth Management Inc. now owns 5,935 shares of the company’s stock worth $95,000 after purchasing an additional 2,650 shares in the last quarter. Finally, Rockefeller Capital Management L.P. purchased a new position in Cinemark during the fourth quarter worth about $100,000. Institutional investors and hedge funds own 93.02% of the company’s stock.

Cinemark Stock Up 0.1 %

Shares of NYSE CNK opened at $18.34 on Tuesday. Cinemark Holdings, Inc. has a 1 year low of $13.37 and a 1 year high of $23.15. The firm’s 50 day moving average price is $16.24 and its 200 day moving average price is $16.33. The firm has a market cap of $2.21 billion, a P/E ratio of -7.61 and a beta of 2.15. The company has a debt-to-equity ratio of 8.60, a quick ratio of 1.09 and a current ratio of 1.11.

Cinemark (NYSE:CNK – Get Rating) last posted its quarterly earnings results on Friday, May 6th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.01). The company had revenue of $460.50 million for the quarter, compared to analysts’ expectations of $454.52 million. Cinemark had a negative return on equity of 85.71% and a negative net margin of 15.54%. The business’s revenue for the quarter was up 302.5% on a year-over-year basis. During the same period in the prior year, the business earned ($1.75) EPS. As a group, sell-side analysts anticipate that Cinemark Holdings, Inc. will post -0.41 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Morgan Stanley upgraded shares of Cinemark from an “equal weight” rating to an “overweight” rating and set a $22.00 target price on the stock in a research report on Tuesday, July 19th. Benchmark set a $27.00 price target on shares of Cinemark in a research report on Tuesday, July 19th. StockNews.com lowered shares of Cinemark from a “hold” rating to a “sell” rating in a research report on Wednesday, May 4th. Finally, B. Riley lowered their price target on shares of Cinemark from $29.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, June 21st. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $23.33.

About Cinemark

(Get Rating)

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of June 30, 2022, it operated 522 theatres with 5,868 screens in the United States, and South and Central America. The company was founded in 1984 and is headquartered in Plano, Texas.

See Also

• Get a free copy of the StockNews.com research report on Cinemark (CNK)
• MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
• The Colgate-Palmolive Growth Outlook Brightens 
• Deep Value High Yield Newell Brands Is Ready To Bottom 
• These Stocks Outperformed Last Time There Was A Recession
• Does Rivian’s Stock Still Have A Future?

Want More Great Investing Ideas?